Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
As of 18 November 2026, for the company name Jiangsu Hansoh Pharmaceutical Group Co., Ltd. as recorded, the chemical-drug catalogue lists 74 active records with this name as holder; 75 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
271 acceptance records as first applicant, grouped into 69 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
HS-20118片 · No verified English name 8 records · Latest accepted 2026/10/21
Supplement · 5New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600438 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600437 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600436 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600435 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600270 | Supplement | 2026/07/31 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500153 | New drug | 2025/02/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500152 | New drug | 2025/02/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500151 | New drug | 2025/02/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10560片 · No verified English name 2 records · Latest accepted 2026/10/10
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601250 | New drug | 2026/10/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2601249 | New drug | 2026/10/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10502片 · No verified English name 10 records · Latest accepted 2026/10/09
New drug · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601241 | New drug | 2026/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2601240 | New drug | 2026/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600459 | New drug | 2026/04/17 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600458 | New drug | 2026/04/17 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401300 | New drug | 2024/11/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401299 | New drug | 2024/11/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400620 | New drug | 2024/06/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400619 | New drug | 2024/06/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200738 | New drug | 2022/09/29 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200737 | New drug | 2022/09/29 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10374片 · No verified English name 2 records · Latest accepted 2026/09/23
Supplement · 2
奥莱泊肽注射液 · No verified English name 10 records · Latest accepted 2026/09/07
New drug · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600126 | New drug | 2026/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Name not romanized | CDE ↗ |
| CXHL2601035 | New drug | 2026/08/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2601034 | New drug | 2026/08/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2601033 | New drug | 2026/08/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600084 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600083 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600082 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600081 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600080 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2600079 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10561胶囊 · No verified English name 7 records · Latest accepted 2026/07/23
New drug · 5Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600897 | New drug | 2026/07/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600874 | New drug | 2026/07/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2500076 | Supplement | 2025/03/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2500075 | Supplement | 2025/03/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401351 | New drug | 2024/12/11 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401350 | New drug | 2024/12/11 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401349 | New drug | 2024/12/11 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10542胶囊 · No verified English name 13 records · Latest accepted 2026/07/21
Supplement · 7New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600239 | Supplement | 2026/07/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600238 | Supplement | 2026/07/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600158 | Supplement | 2026/05/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600157 | Supplement | 2026/05/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600156 | Supplement | 2026/05/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2600155 | Supplement | 2026/05/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2500133 | Supplement | 2025/05/14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500165 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500164 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500163 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500162 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500161 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500160 | New drug | 2025/02/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
培莫沙肽注射液 · No verified English name 12 records · Latest accepted 2026/06/25
Supplement · 9New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601189 | Supplement | 2026/06/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2601188 | Supplement | 2026/06/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2601187 | Supplement | 2026/06/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2502265 | Supplement | 2025/11/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2502264 | Supplement | 2025/11/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2502263 | Supplement | 2025/11/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2501149 | Supplement | 2025/06/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2501148 | Supplement | 2025/06/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2501147 | Supplement | 2025/06/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2200022 | New drug | 2022/05/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2200021 | New drug | 2022/05/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2200020 | New drug | 2022/05/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10568注射液 · No verified English name 1 records · Latest accepted 2026/06/10
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600085 | New drug | 2026/06/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Heng Rui Pharmaceuticals Co., Ltd. romanized | CDE ↗ |
HS-10380片 · No verified English name 9 records · Latest accepted 2026/05/25
Supplement · 1New drug · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600149 | Supplement | 2026/05/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401508 | New drug | 2025/01/01 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401060 | New drug | 2024/10/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401059 | New drug | 2024/10/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400441 | New drug | 2024/05/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400440 | New drug | 2024/05/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101829 | New drug | 2021/12/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101828 | New drug | 2021/12/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101827 | New drug | 2021/12/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-20136-2注射液 · No verified English name 4 records · Latest accepted 2026/04/24
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600491 | New drug | 2026/04/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600490 | New drug | 2026/04/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600489 | New drug | 2026/04/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600488 | New drug | 2026/04/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10541片 · No verified English name 2 records · Latest accepted 2026/03/07
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600279 | New drug | 2026/03/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600278 | New drug | 2026/03/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
甲磺酸阿美替尼片 · No verified English name 8 records · Latest accepted 2026/03/05
New drug · 7Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600038 | New drug | 2026/03/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2400127 | New drug | 2024/11/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2400077 | New drug | 2024/08/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2400060 | New drug | 2024/07/19 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2101945 | Supplement | 2021/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101260 | New drug | 2021/07/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2101017 | New drug | 2021/05/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2100033 | New drug | 2021/01/19 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10522片 · No verified English name 6 records · Latest accepted 2026/02/10
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600164 | New drug | 2026/02/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600163 | New drug | 2026/02/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600162 | New drug | 2026/02/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600158 | New drug | 2026/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600157 | New drug | 2026/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600156 | New drug | 2026/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-20136注射液 · No verified English name 6 records · Latest accepted 2026/02/05
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600151 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600150 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600149 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600148 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600147 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600146 | New drug | 2026/02/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10566植入剂 · No verified English name 2 records · Latest accepted 2026/01/10
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600054 | New drug | 2026/01/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600053 | New drug | 2026/01/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10587片 · No verified English name 2 records · Latest accepted 2026/01/08
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600038 | New drug | 2026/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Changzhou Heng Bang Pharma Co., Ltd. romanized | CDE ↗ |
| CXHL2600037 | New drug | 2026/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Changzhou Heng Bang Pharma Co., Ltd. romanized | CDE ↗ |
HS-10241片 · No verified English name 8 records · Latest accepted 2026/01/07
New drug · 6Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600026 | New drug | 2026/01/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600025 | New drug | 2026/01/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500608 | New drug | 2025/06/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500607 | New drug | 2025/06/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2300225 | Supplement | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2300224 | Supplement | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101262 | New drug | 2021/07/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101261 | New drug | 2021/07/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10529胶囊 · No verified English name 1 records · Latest accepted 2026/01/07
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600020 | New drug | 2026/01/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10504片 · No verified English name 3 records · Latest accepted 2025/12/05
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501339 | New drug | 2025/12/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2501338 | New drug | 2025/12/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400034 | New drug | 2024/01/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10383-B片 · No verified English name 3 records · Latest accepted 2025/11/06
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501213 | New drug | 2025/11/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2501212 | New drug | 2025/11/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2501211 | New drug | 2025/11/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10510片 · No verified English name 3 records · Latest accepted 2025/06/10
Supplement · 1New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500160 | Supplement | 2025/06/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500244 | New drug | 2025/03/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500243 | New drug | 2025/03/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10516胶囊 · No verified English name 8 records · Latest accepted 2025/05/21
New drug · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500493 | New drug | 2025/05/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500492 | New drug | 2025/05/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500031 | New drug | 2025/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500030 | New drug | 2025/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301032 | New drug | 2023/09/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301031 | New drug | 2023/09/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300341 | New drug | 2023/03/31 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300340 | New drug | 2023/03/31 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
盐酸(R)-氯胺酮注射液 · No verified English name 3 records · Latest accepted 2025/03/05
Supplement · 1New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500043 | Supplement | 2025/03/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2401161 | New drug | 2024/11/02 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2401159 | New drug | 2024/11/02 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10529片 · No verified English name 2 records · Latest accepted 2025/02/09
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500182 | New drug | 2025/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500181 | New drug | 2025/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10501片 · No verified English name 8 records · Latest accepted 2025/01/21
Supplement · 3New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500015 | Supplement | 2025/01/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2500014 | Supplement | 2025/01/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2500013 | Supplement | 2025/01/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301241 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301240 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301239 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301238 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301236 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10506片 · No verified English name 5 records · Latest accepted 2025/01/08
Supplement · 1New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500004 | Supplement | 2025/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300234 | New drug | 2023/02/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300233 | New drug | 2023/02/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300031 | New drug | 2023/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300030 | New drug | 2023/01/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10370片 · No verified English name 4 records · Latest accepted 2024/12/24
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401437 | New drug | 2024/12/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400420 | New drug | 2024/04/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101738 | New drug | 2021/12/14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101737 | New drug | 2021/12/14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-20094注射液 · No verified English name 12 records · Latest accepted 2024/12/24
Supplement · 9New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400298 | Supplement | 2024/12/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400092 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400091 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400090 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400089 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400088 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400087 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400086 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400085 | Supplement | 2024/04/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101148 | New drug | 2021/05/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101147 | New drug | 2021/05/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101146 | New drug | 2021/05/24 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 6 records · Latest accepted 2024/12/21
Supplement · 4Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402177 | Supplement | 2024/12/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2402176 | Supplement | 2024/12/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2301819 | Supplement | 2023/08/16 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2301818 | Supplement | 2023/08/16 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2101474 | Generic | 2021/07/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2101473 | Generic | 2021/07/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10501-2 · No verified English name 6 records · Latest accepted 2024/12/12
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401363 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401362 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401361 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401359 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401358 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401357 | New drug | 2024/12/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10518胶囊 · No verified English name 10 records · Latest accepted 2024/11/08
New drug · 7Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2401202 | New drug | 2024/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401201 | New drug | 2024/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2401200 | New drug | 2024/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400175 | Supplement | 2024/08/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400174 | Supplement | 2024/08/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2400173 | Supplement | 2024/08/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400304 | New drug | 2024/03/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400303 | New drug | 2024/03/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400302 | New drug | 2024/03/26 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300398 | New drug | 2023/04/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
Empagliflozin Tablets 3 records · Latest accepted 2024/11/08
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401846 | Supplement | 2024/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2401845 | Supplement | 2024/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2301566 | Supplement | 2023/07/13 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Selexipag Tablets 2 records · Latest accepted 2024/10/22
Supplement · 2
Paliperidone Extend-release Tablets 2 records · Latest accepted 2024/08/29
Supplement · 2
Enzalutamide Soft Capsules 1 records · Latest accepted 2024/07/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401056 | Supplement | 2024/07/17 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
艾米替诺福韦片 · No verified English name 2 records · Latest accepted 2024/07/06
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400998 | Supplement | 2024/07/06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Changzhou Heng Bang Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2101916 | Supplement | 2021/09/29 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Changzhou Heng Bang Pharma Co., Ltd. romanized | CDE ↗ |
奥氮平口溶膜 · No verified English name 2 records · Latest accepted 2024/06/25
Supplement · 2
HS-10382片 · No verified English name 5 records · Latest accepted 2024/02/22
New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400207 | New drug | 2024/02/22 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400206 | New drug | 2024/02/22 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101648 | New drug | 2021/11/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101647 | New drug | 2021/11/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2101646 | New drug | 2021/11/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
聚乙二醇洛塞那肽注射液 · No verified English name 6 records · Latest accepted 2023/12/14
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302713 | Supplement | 2023/12/14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2300178 | Supplement | 2023/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2200019 | Supplement | 2022/02/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2200018 | Supplement | 2022/02/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2101333 | Supplement | 2021/08/03 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2101334 | Supplement | 2021/05/31 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Morinidazole and Sodium Chloride Injection 4 records · Latest accepted 2023/11/27
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302608 | Supplement | 2023/11/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2300883 | Supplement | 2023/04/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2101865 | Supplement | 2021/09/18 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHB2100240 | Supplement | 2021/02/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10398胶囊 · No verified English name 6 records · Latest accepted 2023/11/23
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301308 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301307 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301306 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301305 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301304 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301303 | New drug | 2023/11/23 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10365胶囊 · No verified English name 4 records · Latest accepted 2023/11/17
Supplement · 1New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300234 | Supplement | 2023/11/17 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300374 | New drug | 2023/04/15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2100143 | New drug | 2021/02/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2100142 | New drug | 2021/02/27 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10509片 · No verified English name 3 records · Latest accepted 2023/11/08
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301244 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301243 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301242 | New drug | 2023/11/08 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
Lenalidomide Capsules 2 records · Latest accepted 2023/10/09
Supplement · 2
Fulvestrant Injection 1 records · Latest accepted 2023/10/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302213 | Supplement | 2023/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10511片 · No verified English name 2 records · Latest accepted 2023/08/25
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300911 | New drug | 2023/08/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300910 | New drug | 2023/08/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
甲磺酸氟马替尼片 · No verified English name 2 records · Latest accepted 2023/07/29
Supplement · 2
HS-10353胶囊 · No verified English name 2 records · Latest accepted 2023/05/09
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2300107 | Supplement | 2023/05/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHB2300106 | Supplement | 2023/05/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
Vortioxetine Hydrobromide Tablets 1 records · Latest accepted 2022/10/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201858 | Supplement | 2022/10/12 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Tedizolid Phosphate For Injection 1 records · Latest accepted 2022/04/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200653 | Generic | 2022/04/25 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Vinorelbine Tartrate Soft Capsules 2 records · Latest accepted 2022/03/28
Generic · 2
Regorafenib Tablets 1 records · Latest accepted 2022/03/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200448 | Generic | 2022/03/15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10386片 · No verified English name 2 records · Latest accepted 2022/02/21
New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200104 | New drug | 2022/02/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200103 | New drug | 2022/02/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
HS-10383片 · No verified English name 2 records · Latest accepted 2021/10/22
New drug · 2
培化西海马肽注射液 · No verified English name 3 records · Latest accepted 2021/09/30
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2101045 | New drug | 2021/09/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2101044 | New drug | 2021/09/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHS2101043 | New drug | 2021/09/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Agomelatine Tablets 1 records · Latest accepted 2021/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150887 | Supplement | 2021/09/29 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Carfilzomib For Injection 3 records · Latest accepted 2021/09/07
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101695 | Generic | 2021/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2101694 | Generic | 2021/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CYHS2101693 | Generic | 2021/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Nintedanib Esilate Soft Capsules 2 records · Latest accepted 2021/09/06
Generic · 2
Rabeprazole Sodium Enteric-coated Tablets 1 records · Latest accepted 2021/08/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150823 | Supplement | 2021/08/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10342片 · No verified English name 1 records · Latest accepted 2021/08/17
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101407 | New drug | 2021/08/17 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10352片 · No verified English name 4 records · Latest accepted 2021/08/03
New drug · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101356 | New drug | 2021/08/03 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101355 | New drug | 2021/08/03 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2101034 | Supplement | 2021/05/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHB2101033 | Supplement | 2021/05/20 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10375片 · No verified English name 2 records · Latest accepted 2021/07/28
New drug · 2
HS-10381胶囊 · No verified English name 3 records · Latest accepted 2021/07/28
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101336 | New drug | 2021/07/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101335 | New drug | 2021/07/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| CXHL2101334 | New drug | 2021/07/28 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Pralatrexate Injection 1 records · Latest accepted 2021/06/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101296 | Generic | 2021/06/15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10376片 · No verified English name 2 records · Latest accepted 2021/05/27
New drug · 2
Cefdinir Capsules 1 records · Latest accepted 2021/04/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101200 | Supplement | 2021/04/30 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
HS-10360片 · No verified English name 2 records · Latest accepted 2021/01/21
New drug · 2
Pemetrexed Disodium for Injection 1 records · Latest accepted 2021/01/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2140005 | Supplement | 2021/01/14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Changes in the last 90 days
16 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 11 applicationsNo longer listed under review: 5 applications
- 2026/10/30No longer listed under review
奥莱泊肽注射液 · No verified English name
CXHL2601035
Fact date: 2026/10/30 · Date added to this site: 2026/10/30
Accepted: 2026/08/21
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/30No longer listed under review
奥莱泊肽注射液 · No verified English name
CXHL2601034
Fact date: 2026/10/30 · Date added to this site: 2026/10/30
Accepted: 2026/08/21
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/30No longer listed under review
奥莱泊肽注射液 · No verified English name
CXHL2601033
Fact date: 2026/10/30 · Date added to this site: 2026/10/30
Accepted: 2026/08/21
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/27No longer listed under review
HS-10374片 · No verified English name
CXHB2600398
Fact date: 2026/10/27 · Date added to this site: 2026/10/27
Accepted: 2026/09/23
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/27No longer listed under review
HS-10374片 · No verified English name
CXHB2600397
Fact date: 2026/10/27 · Date added to this site: 2026/10/27
Accepted: 2026/09/23
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/21Accepted
HS-20118片 · No verified English name
CXHB2600438
Fact date: 2026/10/21 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/21Accepted
HS-20118片 · No verified English name
CXHB2600437
Fact date: 2026/10/21 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/21Accepted
HS-20118片 · No verified English name
CXHB2600436
Fact date: 2026/10/21 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/21Accepted
HS-20118片 · No verified English name
CXHB2600435
Fact date: 2026/10/21 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/10Accepted
HS-10560片 · No verified English name
CXHL2601250
Fact date: 2026/10/10 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/10Accepted
HS-10560片 · No verified English name
CXHL2601249
Fact date: 2026/10/10 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/09Accepted
HS-10502片 · No verified English name
CXHL2601241
Fact date: 2026/10/09 · Date added to this site: 2026/10/21
View source ↗ - 2026/10/09Accepted
HS-10502片 · No verified English name
CXHL2601240
Fact date: 2026/10/09 · Date added to this site: 2026/10/21
View source ↗ - 2026/09/23Accepted
HS-10374片 · No verified English name
CXHB2600398
Fact date: 2026/09/23 · Date added to this site: 2026/10/21
View source ↗ - 2026/09/23Accepted
HS-10374片 · No verified English name
CXHB2600397
Fact date: 2026/09/23 · Date added to this site: 2026/10/21
View source ↗ - 2026/09/07Accepted
奥莱泊肽注射液 · No verified English name
CXHS2600126
Fact date: 2026/09/07 · Date added to this site: 2026/10/21
View source ↗
Under review
17 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| HS-20118片 · No verified English name | CXHB2600438 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-20118片 · No verified English name | CXHB2600437 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-20118片 · No verified English name | CXHB2600436 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-20118片 · No verified English name | CXHB2600435 | Supplement | 2026/10/21 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-10560片 · No verified English name | CXHL2601250 | New drug | 2026/10/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-10560片 · No verified English name | CXHL2601249 | New drug | 2026/10/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-10502片 · No verified English name | CXHL2601241 | New drug | 2026/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| HS-10502片 · No verified English name | CXHL2601240 | New drug | 2026/10/09 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600126 | New drug | 2026/09/07 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Name not romanized | CDE ↗ |
| HS-10568注射液 · No verified English name | CXHS2600085 | New drug | 2026/06/10 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Heng Rui Pharmaceuticals Co., Ltd. romanized | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600084 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600083 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600082 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600081 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600080 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 奥莱泊肽注射液 · No verified English name | CXHS2600079 | New drug | 2026/06/04 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 甲磺酸阿美替尼片 · No verified English name | CXHS2600038 | New drug | 2026/03/05 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
Catalogue holder records
74 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Carfilzomib For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20254955 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20254957 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carfilzomib For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20254956 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Selexipag Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20249717 | 2024/12/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20234074 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20234073 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20233762 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20233761 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vinorelbine Tartrate Soft Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20233075 | 2023/01/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Icatibant Acetate Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hengrui Pharmaceuticals Co.,Ltd. | 国药准字H20223894 | 2022/11/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Agomelatine Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20143375 | 2022/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rabeprazole Sodium Enteric-coated Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20020330 | 2022/07/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Palbociclib Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223445 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223446 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223447 | 2022/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Deferasirox Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223301 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223282 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223303 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Deferasirox Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20223302 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Zolpidem Tartrate Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20000114 | 2021/12/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Sodium for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213895 | 2021/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fulvestrant Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213861 | 2021/11/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20030472 | 2021/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20205050 | 2021/09/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Micafungin Sodium for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20183111 | 2021/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Enzalutamide Soft Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213660 | 2021/08/25 | Not stated by source | CDE ↗ |
| Azacitidine For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213659 | 2021/08/25 | Not stated by source | CDE ↗ |
| Bivalirudin for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20140057 | 2021/08/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lurasidone Hydrochloride Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213461 | 2021/06/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lurasidone Hydrochloride Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213460 | 2021/06/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Erlotinib Hydrochloride Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213412 | 2021/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Erlotinib Hydrochloride Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213411 | 2021/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 酒石酸伐尼克兰片 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213294 | 2021/04/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 酒石酸伐尼克兰片 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213295 | 2021/04/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213223 | 2021/03/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213224 | 2021/03/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213143 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vinorelbine Tartrate Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H19990278 | 2021/02/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Decitabine For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20130067 | 2021/02/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Decitabine For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20153045 | 2021/02/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dabigatran Etexilate Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213088 | 2021/01/30 | Not stated by source | CDE ↗ |
| Dabigatran Etexilate Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20213087 | 2021/01/30 | Not stated by source | CDE ↗ |
| Pemetrexed Disodium for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20093996 | — | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20184068 | 2020/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid and Glucose Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20150223 | 2020/12/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20030104 | 2020/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20030105 | 2020/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20051288 | 2020/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tigecycline for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20123394 | 2020/11/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Saxagliptin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203537 | 2020/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203536 | 2020/10/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bortezomib For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20173307 | 2020/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20173306 | 2020/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Empagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203363 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Empagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203364 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203262 | 2020/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203263 | 2020/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Extend-release Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203266 | 2020/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paliperidone Extend-release Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203265 | 2020/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203230 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203233 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203229 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sunitinib Hard Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20203186 | 2020/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Canagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20193393 | 2019/12/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Canagliflozin Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20193392 | 2019/12/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Linezolid Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20193364 | 2019/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fosaprepitant Dimeglumine for Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20193289 | 2019/09/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefdinir Capsules | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20080107 | 2019/05/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambrisentan Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20183321 | 2018/07/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Morinidazole and Sodium Chloride Injection | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20140022 | 2014/02/24 | Innovative drug | CDE ↗ |
| Selexipag Tablets | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20249718 | 2024/12/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 培莫沙肽注射液 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20230021 | 2023/06/30 | Innovative drug | CDE ↗ |
| 培莫沙肽注射液 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20230019 | 2023/06/30 | Innovative drug | CDE ↗ |
| 培莫沙肽注射液 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 国药准字H20230020 | 2023/06/30 | Innovative drug | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
75 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 奥莱泊肽 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20260000396 | I | 2026/05/12 | CDE ↗ |
| 甲磺酸达麦利替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20260000069 | I | 2026/02/02 | CDE ↗ |
| 瑞森替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20250000975 | I | 2025/09/10 | CDE ↗ |
| 磷酸特地唑胺 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20220000231 | A | 2023/11/01 | CDE ↗ |
| 瑞戈非尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20220000083 | A | 2024/01/24 | CDE ↗ |
| 培莫沙肽 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000789 | A | 2026/09/18 | CDE ↗ |
| 乙磺酸尼达尼布 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000712 | A | 2023/09/06 | CDE ↗ |
| 卡非佐米 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000613 | A | 2025/09/09 | CDE ↗ |
| 达格列净 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000556 | A | 2023/06/29 | CDE ↗ |
| 司来帕格 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000318 | A | 2025/01/13 | CDE ↗ |
| 普拉曲沙 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20210000052 | I | 2021/02/02 | CDE ↗ |
| 哌柏西利 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200001242 | A | 2022/10/26 | CDE ↗ |
| 地拉罗司 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200001185 | A | 2026/09/29 | CDE ↗ |
| 苹果酸卡博替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000945 | I | 2020/09/08 | CDE ↗ |
| 富马酸艾米替诺福韦 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000937 | A | 2026/09/29 | CDE ↗ |
| 醋酸艾替班特 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000916 | A | 2023/01/17 | CDE ↗ |
| 艾司奥美拉唑钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000456 | A | 2026/06/11 | CDE ↗ |
| 恩扎卢胺 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000360 | A | 2026/05/20 | CDE ↗ |
| 盐酸鲁拉西酮 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000367 | A | 2026/04/04 | CDE ↗ |
| HS-10353 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000280 | I | 2022/10/09 | CDE ↗ |
| 甲磺酸阿美替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190021594 | A | 2026/06/24 | CDE ↗ |
| HS-10356 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000232 | I | 2020/03/12 | CDE ↗ |
| 阿扎胞苷 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000238 | A | 2026/07/23 | CDE ↗ |
| HS-10352 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000191 | I | 2022/10/09 | CDE ↗ |
| 氟维司群 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190021481 | A | 2026/03/18 | CDE ↗ |
| 聚乙二醇洛塞那肽 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190021572 | A | 2024/10/24 | CDE ↗ |
| 氢溴酸伏硫西汀 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190021303 | A | 2026/09/15 | CDE ↗ |
| 甲磺酸氟马替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001782 | A | 2026/08/05 | CDE ↗ |
| 酒石酸伐尼克兰 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20200000047 | A | 2026/01/23 | CDE ↗ |
| 地西他滨 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190009854 | A | — | CDE ↗ |
| 替加环素 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190009813 | A | — | CDE ↗ |
| 酒石酸长春瑞滨 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190009566 | A | — | CDE ↗ |
| 阿戈美拉汀 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190009369 | A | 2025/07/12 | CDE ↗ |
| 盐酸多奈哌齐 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190008579 | A | 2025/05/21 | CDE ↗ |
| 瑞格列奈 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007915 | A | 2025/05/21 | CDE ↗ |
| 头孢泊肟酯 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007914 | A | — | CDE ↗ |
| 比伐芦定 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007413 | A | 2024/01/17 | CDE ↗ |
| 阿立哌唑 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007394 | A | 2023/09/01 | CDE ↗ |
| 吗啉硝唑 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007383 | A | 2025/06/05 | CDE ↗ |
| 利塞膦酸钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007262 | A | 2023/04/05 | CDE ↗ |
| 甲磺酸伊马替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007164 | A | 2024/10/30 | CDE ↗ |
| 头孢地尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190007005 | A | 2023/03/24 | CDE ↗ |
| 硼替佐米 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190006944 | A | 2023/03/24 | CDE ↗ |
| 依替巴肽 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190006754 | A | 2026/09/29 | CDE ↗ |
| 盐酸吉西他滨 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003539 | A | 2025/03/28 | CDE ↗ |
| 雷贝拉唑钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003533 | A | — | CDE ↗ |
| 培美曲塞二钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003532 | A | — | CDE ↗ |
| 罗格列酮 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003531 | A | 2025/05/27 | CDE ↗ |
| 酒石酸唑吡坦 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003530 | A | 2025/05/21 | CDE ↗ |
| 盐酸头孢卡品酯 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003529 | A | 2025/05/21 | CDE ↗ |
| 枸橼酸莫沙必利 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003525 | A | 2025/05/27 | CDE ↗ |
| 硫酸头孢噻利 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003519 | A | 2025/05/27 | CDE ↗ |
| 奥氮平 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003507 | A | 2025/05/21 | CDE ↗ |
| 米格列奈钙 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190003505 | A | 2025/05/21 | CDE ↗ |
| 利奈唑胺 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190002493 | A | 2026/01/10 | CDE ↗ |
| 苹果酸舒尼替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001776 | A | 2025/01/10 | CDE ↗ |
| 卡格列净 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001775 | A | 2024/07/27 | CDE ↗ |
| 甲磺酸达比加群酯 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190000468 | A | 2025/12/03 | CDE ↗ |
| 马来酸阿法替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001749 | A | 2025/04/17 | CDE ↗ |
| 帕利哌酮 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20190000208 | A | 2025/05/21 | CDE ↗ |
| 沙格列汀 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001500 | A | 2025/12/08 | CDE ↗ |
| 来那度胺 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001437 | A | 2025/10/10 | CDE ↗ |
| 恩格列净 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001426 | A | 2025/05/27 | CDE ↗ |
| 地西他滨 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001314 | A | 2023/07/28 | CDE ↗ |
| 盐酸厄洛替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180001149 | A | 2025/12/23 | CDE ↗ |
| 培美曲塞二钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20180000763 | A | 2025/05/21 | CDE ↗ |
| 替加环素 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170002139 | A | 2026/09/15 | CDE ↗ |
| 酒石酸长春瑞滨 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001949 | A | 2026/06/24 | CDE ↗ |
| 琥珀酸普芦卡必利 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001605 | A | 2025/01/24 | CDE ↗ |
| 安立生坦 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001589 | A | 2024/01/17 | CDE ↗ |
| 福沙匹坦双葡甲胺 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001584 | A | 2024/04/19 | CDE ↗ |
| 阿哌沙班 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001531 | A | 2025/01/04 | CDE ↗ |
| 维格列汀 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170001530 | A | 2023/09/01 | CDE ↗ |
| 米卡芬净钠 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20170000513 | A | 2023/04/05 | CDE ↗ |
| 氘索昔替尼 · No verified English name | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Y20260000873 | I | 2026/11/13 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
26 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| HS-10560片 · No verified English name | CXHL2601251 | New drug | 2026/10/10 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10582片 · No verified English name | CXHB2600349 | Supplement | 2026/09/02 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10382片 · No verified English name | CXHB2600344 | Supplement | 2026/08/28 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10582片 · No verified English name | CXHL2600782 | New drug | 2026/07/01 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10582片 · No verified English name | CXHL2600781 | New drug | 2026/07/01 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10529胶囊 · No verified English name | CXHB2600106 | Supplement | 2026/04/15 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 甲磺酸达麦利替尼片 · No verified English name | CXHS2600035 | New drug | 2026/02/27 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 甲磺酸达麦利替尼片 · No verified English name | CXHS2600034 | New drug | 2026/02/27 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-20152注射液 · No verified English name | CXHL2600052 | New drug | 2026/01/10 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-20152注射液 · No verified English name | CXHL2600051 | New drug | 2026/01/10 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-20138注射液 · No verified English name | CXHL2600045 | New drug | 2026/01/09 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10365胶囊 · No verified English name | CXHS2500127 | New drug | 2025/10/23 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10374片 · No verified English name | CXHB2500193 | Supplement | 2025/07/18 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10384片 · No verified English name | CXHB2500126 | Supplement | 2025/05/09 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10384片 · No verified English name | CXHB2500125 | Supplement | 2025/05/09 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10374片 · No verified English name | CXHB2400106 | Supplement | 2024/05/08 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10374片 · No verified English name | CXHB2400105 | Supplement | 2024/05/08 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10504片 · No verified English name | CXHL2400035 | New drug | 2024/01/09 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 米卡芬净钠 · No verified English name | JTH2300261 | Not stated by source | 2023/11/10 | U. S. Pharmacopiea (Mei Guo Yao Dian Wei Yuan Hui) romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10501片 · No verified English name | CXHL2301237 | New drug | 2023/11/08 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| HS-10511片 · No verified English name | CXHL2300909 | New drug | 2023/08/25 | Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 他达拉非口溶膜 · No verified English name | CXHS2101034 | New drug | 2021/08/03 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd.; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| 他达拉非口溶膜 · No verified English name | CXHS2101033 | New drug | 2021/08/03 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd.; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Selexipag Tablets | CYHS2101338 | Generic | 2021/06/25 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Selexipag Tablets | CYHS2101337 | Generic | 2021/06/25 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
| Eptifibatide Injection | CYHB2101147 | Supplement | 2021/04/21 | Shanxi De Yuan Tang Pharma Co., Ltd. romanized; Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.